Showing results (251-260 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|October 20, 2022
Correction to "A Stepwise Targeting Curcumin Derivative, Ser@TPP@CUR, for Acute Kidney Injury"Xia Yan, Xue-Ying Tan, Yi-Xuan Li, et al.ACS Medicinal Chemistry Letters|October 20, 2022
Development of an N-Terminal BRD4 Bromodomain-Targeted DegraderAnand Divakaran, Cole R Scholtz, Huda Zahid, et al.ACS Medicinal Chemistry Letters|October 20, 2022
Design, Synthesis, and Monoamine Oxidase B Selective Inhibitory Activity of N-Arylated Heliamine AnaloguesMakito Yamada, Yu Hirose, Bangzhong Lin, et al.ACS Medicinal Chemistry Letters|October 20, 2022
Highly Potent and Oral Macrocyclic Peptides as a HIV-1 Protease Inhibitor: mRNA Display-Derived Hit-to-Lead OptimizationYoshifumi Kusumoto, Kyohei Hayashi, Soichiro Sato, et al.ACS Medicinal Chemistry Letters|October 21, 2022
Selective Cyclin-Dependent Kinase Inhibitors and Their Application in Cancer TherapyRobert B KargboACS Medicinal Chemistry Letters|October 21, 2022
Factor XI Activation Inhibitors for Treating Thromboses, Embolism, Hypercoagulability, or Fibrotic ChangesRam W SabnisACS Medicinal Chemistry Letters|October 21, 2022
Boron-Containing Pyrazole Compounds as JAK Inhibitors for Treating Inflammation, Autoimmune Diseases, and CancerRam W SabnisACS Medicinal Chemistry Letters|October 21, 2022
Potential Treatment for Obsessive-Compulsive DisorderRobert B KargboACS Medicinal Chemistry Letters|July 21, 2015
Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse TranscriptaseBryan D Cox, Anthony R Prosser, Yongnian Sun, et al.ACS Medicinal Chemistry Letters|July 21, 2015
Exploration of Pharmacophore in Chrysosplenol C as Activator in Ventricular Myocyte ContractionEeda Venkateswararao, Min-Jeong Son, Niti Sharma, et al.Pageof 438